Advancing Genetic
Diagnostics for
Precise Medicine.

Impact Genetics provides cost-effective, high quality genetic testing for select diseases.

In collaboration with our leading scientists and clinical care providers, we continually refine tests to maximize sensitivity. New scientific discoveries, genetic data and clinical knowledge flow freely to maximize health impact. Impact Genetics’ service delivery team is committed to supporting doctors and genetic specialists with outstanding service.

  • March 23rd, 2017 – Impact Genetics launches BAP1 Tumor Predisposition Syndrome (BAP1-TPDS) Genetic Test. Full BAP1 gene sequencing, copy number assessment, expert reporting and interpretation with comprehensive pre-test and/or post-test genetic counseling, provided by LabCorp Integrated Genetics, using telegenetics. More information.


Joan’s Story – Uveal Melanoma Prognostic Genetic Testing

Joan speaks about her decision to undergo prognostic UM tumor testing. This is followed by interviews with Dr. Tara McCannel (UCLA) and Dr. Bertil Damato (UCSF) who discuss how they use results of UM genetic testing and the importance of this testing to their patients.


Dynacare Centre for Precision Diagnostics – Bowmanville, Ontario

Specialized scientists, Impact Genetics and Dynacare are working together to support healthy lives around the world. The Dynacare Centre for Precision Diagnostics in Bowmanville, Ontario has partnered with internationally sought-after Canadian scientists to provide cutting-edge genetic test solutions globally.



We offer the following clinical genetic tests in our CAP/CLIA certified lab.

Why choose us?
  • Cost effective
  • Documented high diagnostic sensitivity
  • Provided by disease experts
  • Flexible billing and personal support
  • Quick turn-around times
  • Comprehensive and informative reports

More about our services

News and Events
MAR 23rd – Impact Genetics launches BAP1 Tumor Predisposition Syndrome (BAP1-TPDS) Genetic Test. More Information.
MAR 16th – Now Available: Faster test turn around times, updated and improved test order forms. More Information.
FEB 13th – Our Uveal Melanoma Prognostic Genetic Test now includes SF3B1, EIF1AX, GNAQ and GNA11 sequencing for tumor confirmation in chromosomally normal tumor samples. More Information.

More news and events